Gambaran Umum
Algorae Pharmaceuticals Limited, based in the United Kingdom, operates predominantly in the pharmaceutical sector. The company is primarily engaged in the development and commercialization of innovative medical therapies, with a significant focus on oncology and neurological diseases. Recent key projects include the advanced clinical trials of a novel drug aimed at treating a rare form of cancer, which has shown promising results in early analyses. Additionally, Algorae Pharmaceuticals has been expanding its portfolio into bio-tech driven solutions to address chronic ailments. This strategic diversification underscores the company’s commitment to leveraging cutting-edge science to improve health outcomes. Through its Depositary Receipt (Common for international investors), Algorae Pharmaceuticals ensures broad market access, supporting its global expansion and investment in research and development.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Algorae Pharmaceuticals Limited - Equity Warrant per 2024 Dec 31 adalah 0.13 MM.
- Nilai operating income untuk Algorae Pharmaceuticals Limited - Equity Warrant per 2024 Dec 31 adalah -0.74 MM.
- Nilai net income untuk Algorae Pharmaceuticals Limited - Equity Warrant per 2024 Dec 31 adalah -1.30 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2024-12-31 | 0.13 | -0.74 | -1.30 |
| 2024-09-30 | 0.13 | -1.16 | -1.70 |
| 2024-06-30 | 0.13 | -1.58 | -2.10 |
| 2024-03-31 | 0.08 | -1.74 | -2.17 |
| 2023-12-31 | 0.04 | -1.80 | -2.25 |
| 2023-09-30 | 0.04 | -1.64 | -2.18 |
| 2023-06-30 | 0.04 | -1.48 | -2.11 |
| 2023-03-31 | 0.02 | -1.63 | -2.32 |
| 2022-12-31 | 0.00 | -1.78 | -2.53 |
| 2022-09-30 | 0.00 | -1.62 | -2.24 |
| 2022-06-30 | 0.00 | -1.46 | -1.96 |
| 2022-03-31 | 0.08 | -1.42 | -1.75 |
| 2021-12-31 | 0.16 | -1.38 | -1.55 |
| 2021-09-30 | 0.21 | -1.36 | -1.51 |
| 2021-06-30 | 0.27 | -1.34 | -1.46 |
| 2021-03-31 | 0.35 | -1.36 | -1.42 |
| 2020-12-31 | 0.43 | -1.37 | -1.39 |
| 2020-09-30 | 0.49 | -1.60 | -1.18 |
| 2020-06-30 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Algorae Pharmaceuticals Limited - Equity Warrant pada 2024 Dec 31 adalah -0.00.
- laba per saham yang terdilusi untuk Algorae Pharmaceuticals Limited - Equity Warrant pada 2024 Dec 31 adalah -0.00.
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2024-12-31 | -0.00 | -0.00 |
| 2024-09-30 | -0.00 | -0.00 |
| 2024-06-30 | -0.00 | -0.00 |
| 2024-03-31 | -0.00 | -0.00 |
| 2023-12-31 | -0.00 | -0.00 |
| 2023-09-30 | -0.00 | -0.00 |
| 2023-06-30 | -0.00 | -0.00 |
| 2023-03-31 | -0.00 | -0.00 |
| 2022-12-31 | -0.00 | -0.00 |
| 2022-09-30 | -0.00 | -0.00 |
| 2022-06-30 | -0.00 | -0.00 |
| 2022-03-31 | -0.00 | -0.00 |
| 2021-12-31 | -0.00 | -0.00 |
| 2021-09-30 | -0.00 | -0.00 |
| 2021-06-30 | -0.00 | -0.00 |
| 2021-03-31 | -0.00 | -0.00 |
| 2020-12-31 | -0.00 | -0.00 |
| 2020-09-30 | -0.00 | -0.00 |
| 2020-06-30 | -0.00 | -0.00 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Algorae Pharmaceuticals Limited - Equity Warrant per 2024 Dec 31 adalah -1.22 MM.
- Nilai cash from investing activities untuk Algorae Pharmaceuticals Limited - Equity Warrant per 2024 Dec 31 adalah 0.90 MM.
- Nilai kas dari aktivitas pendanaan untuk Algorae Pharmaceuticals Limited - Equity Warrant per 2024 Dec 31 adalah 0.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2024-12-31 | -1.22 | 0.90 | 0.00 |
| 2024-09-30 | -1.37 | 0.31 | 0.26 |
| 2024-06-30 | -1.52 | -0.28 | 0.52 |
| 2024-03-31 | -1.68 | -0.64 | 1.45 |
| 2023-12-31 | -1.84 | -0.99 | 2.37 |
| 2023-09-30 | -1.91 | -0.01 | 2.11 |
| 2023-06-30 | -1.99 | 0.98 | 1.85 |
| 2023-03-31 | -2.29 | 0.98 | 1.57 |
| 2022-12-31 | -2.60 | 0.99 | 1.29 |
| 2022-09-30 | -2.32 | 0.52 | 2.99 |
| 2022-06-30 | -2.04 | 0.04 | 4.69 |
| 2022-03-31 | -1.74 | 0.09 | 4.03 |
| 2021-12-31 | -1.43 | 0.15 | 3.38 |
| 2021-09-30 | -1.45 | 0.13 | 1.67 |
| 2021-06-30 | -1.46 | 0.11 | -0.04 |
| 2021-03-31 | -1.37 | 0.08 | -0.06 |
| 2020-12-31 | -1.28 | 0.05 | -0.08 |
| 2020-09-30 | -2.19 | 0.64 | -0.06 |
| 2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | -0.79 | ||
| 2024-03-31 | -0.79 | ||
| 2023-12-31 | -0.79 | 0.44 | 0.44 |
| 2023-09-30 | |||
| 2023-06-30 | -0.74 | 0.41 | 0.41 |
| 2023-03-31 | -0.60 | 0.37 | 0.37 |
| 2022-12-31 | |||
| 2022-09-30 | -0.57 | 0.47 | 0.47 |
| 2022-06-30 | -0.66 | 0.32 | 0.32 |
| 2022-03-31 | -0.59 | 0.25 | 0.25 |
| 2021-12-31 | -0.66 | 0.25 | 0.25 |
| 2021-09-30 | -0.38 | 0.14 | 0.14 |
| 2021-06-30 | -0.39 | 0.41 | 0.41 |
| 2021-03-31 | -0.40 | 0.41 | 0.41 |
| 2020-12-31 | -0.41 | 0.25 | 0.25 |
| 2020-09-30 | -0.49 | 0.25 | 0.25 |
| 2020-06-30 | -0.59 | 0.20 | 0.20 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | -1.27 | -1.32 |
| 2024-03-31 | -1.27 | -1.32 |
| 2023-12-31 | 0.86 | 0.88 |
| 2023-09-30 | ||
| 2023-06-30 | 0.83 | 0.83 |
| 2023-03-31 | 0.86 | 0.78 |
| 2022-12-31 | ||
| 2022-09-30 | 1.37 | 1.11 |
| 2022-06-30 | 0.80 | 0.63 |
| 2022-03-31 | 0.67 | 0.62 |
| 2021-12-31 | 0.57 | 0.62 |
| 2021-09-30 | 0.50 | 0.57 |
| 2021-06-30 | 1.91 | 2.25 |
| 2021-03-31 | 1.87 | 1.88 |
| 2020-12-31 | 1.05 | 0.87 |
| 2020-09-30 | 0.91 | 0.95 |
| 2020-06-30 | 0.56 | 0.75 |
Efektivitas Manajemen
- roa untuk Algorae Pharmaceuticals Limited - Equity Warrant pada 2024 Dec 31 adalah -0.56.
- roe untuk Algorae Pharmaceuticals Limited - Equity Warrant pada 2024 Dec 31 adalah -0.36.
- roic untuk Algorae Pharmaceuticals Limited - Equity Warrant pada 2024 Dec 31 adalah -0.70.
- croic untuk Algorae Pharmaceuticals Limited - Equity Warrant pada 2024 Dec 31 adalah -0.42.
- ocroic untuk Algorae Pharmaceuticals Limited - Equity Warrant pada 2024 Dec 31 adalah -0.51.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2024-12-31 | -0.56 | -0.36 | -0.70 | -0.42 | -0.51 |
| 2024-09-30 | -0.56 | -0.47 | -0.70 | -0.42 | -0.51 |
| 2024-06-30 | -0.72 | -0.82 | |||
| 2024-03-31 | -0.72 | -0.82 | |||
| 2023-12-31 | -0.68 | -0.80 | -0.58 | -0.21 | -0.51 |
| 2023-09-30 | -0.49 | -0.52 | -0.56 | -0.03 | -0.53 |
| 2023-06-30 | -0.49 | -0.52 | -0.56 | -0.03 | -0.53 |
| 2023-03-31 | -0.54 | -0.57 | -0.62 | -0.19 | -0.61 |
| 2022-12-31 | -0.50 | -0.55 | -0.82 | 0.25 | -0.85 |
| 2022-09-30 | -0.50 | -0.55 | -0.82 | 0.25 | -0.85 |
| 2022-06-30 | -1.19 | -1.42 | -0.49 | 0.66 | -0.51 |
| 2022-03-31 | -1.07 | -1.27 | -0.43 | 0.59 | -0.43 |
| 2021-12-31 | -0.57 | -0.68 | -0.38 | 0.52 | -0.35 |
| 2021-09-30 | -0.55 | -0.66 | -0.37 | 0.09 | -0.35 |
| 2021-06-30 | -0.43 | -0.51 | -0.91 | -0.87 | -0.91 |
| 2021-03-31 | -0.42 | -0.49 | -0.89 | -0.80 | -0.85 |
| 2020-12-31 | -0.30 | -0.35 | -0.55 | -0.47 | -0.51 |
| 2020-09-30 | -0.25 | -0.30 | -0.47 | -0.62 | -0.87 |
| 2020-06-30 | -0.17 | -0.23 | -0.31 | -0.62 | -0.99 |
Gross Margins
- marjin kotor untuk Algorae Pharmaceuticals Limited - Equity Warrant pada 2024 Dec 31 adalah 1.00.
- marjin bersih untuk Algorae Pharmaceuticals Limited - Equity Warrant pada 2024 Dec 31 adalah -16.74.
- marjin operasi untuk Algorae Pharmaceuticals Limited - Equity Warrant pada 2024 Dec 31 adalah -12.62.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2024-12-31 | 1.00 | -16.74 | -12.62 |
| 2024-09-30 | 1.00 | -16.74 | -12.62 |
| 2024-06-30 | 1.00 | -50.16 | -30.17 |
| 2024-03-31 | 1.00 | -50.16 | -30.17 |
| 2023-12-31 | 1.00 | -50.16 | -30.17 |
| 2023-09-30 | 1.00 | -50.16 | -30.17 |
| 2023-06-30 | 1.00 | -50.16 | -30.17 |
| 2023-03-31 | 1.00 | -102.10 | -67.20 |
| 2022-12-31 | 11.95 | -658.90 | -476.41 |
| 2022-09-30 | 11.95 | -658.90 | -476.41 |
| 2022-06-30 | 11.95 | -574.83 | -428.70 |
| 2022-03-31 | 1.47 | -22.10 | -17.88 |
| 2021-12-31 | 1.48 | -9.98 | -8.88 |
| 2021-09-30 | 1.18 | -7.11 | -6.42 |
| 2021-06-30 | 2.02 | -5.45 | -5.00 |
| 2021-03-31 | 1.78 | -4.06 | -3.86 |
| 2020-12-31 | 2.27 | -3.20 | -3.16 |
| 2020-09-30 | 1.56 | -2.39 | -3.24 |
| 2020-06-30 | -1.22 | -1.75 | -3.31 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) |
